Stephanie L. Lee, MD, PhD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Stephanie L. Lee, Ph.D., M.D., F.A.C.E., E.C.N.U graduated from UC San Diego with a MD and PhD in Physiology and Pharmacology and completed a molecular and clinical fellowship in Endocrinology. Her research interests are to improve the methods to diagnosis and manage thyroid cancer.

Publications

  • Published 2/2/2024

    Goundan PN, Lye T, Markel A, Mamou J, Lee SL. Improved cancer risk stratification of isoechoic thyroid nodules to reduce unnecessary biopsies using quantitative ultrasound. Front Endocrinol (Lausanne). 2024; 15:1326188. PMID: 38370358.

    Read at: PubMed

  • Published 9/27/2023

    Kang H, Drake FT, McAneny D, Lee SL. False-positive Imaging for Papillary Thyroid Cancer Caused by Intraosseous Hemangiomas. JCEM Case Rep. 2023 Sep; 1(5):luad102. PMID: 37908210.

    Read at: PubMed

  • Published 8/1/2023

    Sipos JA, Aloi J, Gianoukakis A, Lee SL, Klopper JP, Kung JT, Lupo MA, Morgenstern D, Prat-Knoll C, Schuetzenmeister A, Goldner WS. Thyroglobulin Cutoff Values for Detecting Excellent Response to Therapy in Patients With Differentiated Thyroid Cancer. J Endocr Soc. 2023 Aug 01; 7(9):bvad102. PMID: 37564885.

    Read at: PubMed

  • Published 10/31/2022

    Sarkar R, Lee SL, Kumar V, Thakur S. Editorial: Thyroid cancer: New perspectives in diagnosis and therapy. Front Pharmacol. 2022; 13:1057731. PMID: 36386151.

    Read at: PubMed

  • Published 2/14/2022

    Pence A, McGrath M, Lee SL, Raines DE. Pharmacological management of severe Cushing's syndrome: the role of etomidate. Ther Adv Endocrinol Metab. 2022; 13:20420188211058583. PMID: 35186251.

    Read at: PubMed

Other Positions

  • Member, BU-BMC Cancer Center
    Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University

Education

  • University of California, San Diego, MD
  • University of California, San Diego, PhD
  • University of California, Santa Barbara, BA